Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Sako

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
PDA Journal of Pharmaceutical Science and Technology|July 23, 2013
Pharmaceutical development of a parenteral formulation of conivaptan hydrochlorideKazutoshi Ban, Ritsu Sonohara, Mitsunobu Yoshida, et al.
Experimental Brain Research|June 19, 2002
Effect of mild hypothermia on energy state recovery following transient forebrain ischemia in the gerbilTeruo Kimura, Kazuhiro Sako, Kunio Tanaka, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2008
Mechanism of controlled drug release from a salting-out taste-masking systemTakayuki Yoshida, Hiroaki Tasaki, Atsushi Maeda, et al.
Journal of Pharmaceutical Sciences|March 6, 2013
Aminoalkylmethacrylate copolymer E improves oral bioavailability of YM466 by suppressing drug-bile interactionShigeo Takemura, Hiromu Kondo, Shunsuke Watanabe, et al.
The Journal of Pharmacy and Pharmacology|September 6, 2017
Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailabilityDaisuke Tsunashima, Kazunari Yamashita, Ken-Ichi Ogawara, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 10, 2016
Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 productionTakayuki Yoshida, Kiyo Nakanishi, Tatsunobu Yoshioka, et al.
Journal of Pharmaceutical Sciences|March 17, 2012
Evaluation of factors affecting gastrointestinal absorption of a novel anticoagulant FX-93 for development of oral formulationShigeo Takemura, Hiromu Kondo, Kenichi Suzumura, et al.
International Journal of Pharmaceutics|March 13, 2012
Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: Evaluation of solid dispersion formulationsTakatsune Yoshida, Ippei Kurimoto, Keiichi Yoshihara, et al.
Drug Development and Industrial Pharmacy|October 16, 2012
Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drugTakatsune Yoshida, Ippei Kurimoto, Keiichi Yoshihara, et al.
Pharmaceutical Research|July 19, 2014
Formulation design and evaluation of liposomal sepantronium bromide (YM155), a small-molecule survivin suppressant, based on pharmacokinetic modeling and simulationKohsuke Shakushiro, Hiroki Kawano, Mari Nakata, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
PDA Journal of Pharmaceutical Science and Technology|July 23, 2013
Pharmaceutical development of a parenteral formulation of conivaptan hydrochlorideKazutoshi Ban, Ritsu Sonohara, Mitsunobu Yoshida, et al.
Experimental Brain Research|June 19, 2002
Effect of mild hypothermia on energy state recovery following transient forebrain ischemia in the gerbilTeruo Kimura, Kazuhiro Sako, Kunio Tanaka, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2008
Mechanism of controlled drug release from a salting-out taste-masking systemTakayuki Yoshida, Hiroaki Tasaki, Atsushi Maeda, et al.
Journal of Pharmaceutical Sciences|March 6, 2013
Aminoalkylmethacrylate copolymer E improves oral bioavailability of YM466 by suppressing drug-bile interactionShigeo Takemura, Hiromu Kondo, Shunsuke Watanabe, et al.
The Journal of Pharmacy and Pharmacology|September 6, 2017
Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailabilityDaisuke Tsunashima, Kazunari Yamashita, Ken-Ichi Ogawara, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 10, 2016
Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 productionTakayuki Yoshida, Kiyo Nakanishi, Tatsunobu Yoshioka, et al.
Journal of Pharmaceutical Sciences|March 17, 2012
Evaluation of factors affecting gastrointestinal absorption of a novel anticoagulant FX-93 for development of oral formulationShigeo Takemura, Hiromu Kondo, Kenichi Suzumura, et al.
International Journal of Pharmaceutics|March 13, 2012
Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: Evaluation of solid dispersion formulationsTakatsune Yoshida, Ippei Kurimoto, Keiichi Yoshihara, et al.
Drug Development and Industrial Pharmacy|October 16, 2012
Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drugTakatsune Yoshida, Ippei Kurimoto, Keiichi Yoshihara, et al.
Pharmaceutical Research|July 19, 2014
Formulation design and evaluation of liposomal sepantronium bromide (YM155), a small-molecule survivin suppressant, based on pharmacokinetic modeling and simulationKohsuke Shakushiro, Hiroki Kawano, Mari Nakata, et al.
Pageof 5